Clinical Trial Update: Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma [NA]

View source ↗

Summary

A completed clinical trial from Fujian Cancer Hospital evaluated intensity-modulated radiotherapy for recurrent T1-2 nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Cancer Recurrent | NA | Status: COMPLETED